SMH
APTO

Sanders Morris Harris’s Aptose Biosciences, Inc. APTO Stock Holding History

Sanders Morris Harris’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-56
Closed -$14.7K – 257
2022
Q4 		$14.7K Sell
56
-1,405
-96% -$377K 0.01% 207
2022
Q3 		$395K Sell
1,461
-815
-36% -$281K 0.1% 164
2022
Q2 		$812K Sell
2,276
-2,930
-56% -$1.4M 0.18% 88
2022
Q1 		$3.19M Buy
5,206
+847
+19% +$468K 0.62% 27
2021
Q4 		$2.92M Buy
4,359
+1,306
+43% +$1.23M 0.51% 36
2021
Q3 		$3.08M Buy
3,053
+953
+45% +$1.19M 0.56% 34
2021
Q2 		$3.08M Buy
2,100
+2,044
+3,650% +$4.45M 0.6% 29
2021
Q1 		$144K Sell
56
-2,000
-97% -$3.97M 0.03% 281
2020
Q4 		$4.23M Buy
2,056
+574
+39% +$1.35M 0.96% 23
2020
Q3 		$4.06M Buy
+1,482
New +$3.7M 1.1% 16
2020
Q2 		– Sell
-25
Closed -$42K – 232
2020
Q1 		$42K Sell
25
-487
-95% -$1.45M 0.04% 116
2019
Q4 		$1.27M Sell
512
-104
-17% -$136K 0.29% 93
2019
Q3 		$539K Buy
616
+136
+28% +$155K 0.13% 137
2019
Q2 		$572K Buy
+480
New +$442K 0.15% 131

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Sanders Morris Harris's APTO Position: Q1 2023 in Review

Sanders Morris Harris sold out of Aptose Biosciences, Inc. (APTO) in Q1 2023, closing a stake of 56 shares — an estimated $14.7K sold.

Sanders Morris Harris first reported a position in APTO in Q2 2019 and held it in 14 quarters. The position peaked at $4.23M in Q4 2020. 44 funds tracked by Wall St. Rank hold APTO as of Q1 2023.

  • Sanders Morris Harris reported no remaining Aptose Biosciences, Inc. position as of Q1 2023 after selling out during the quarter.
  • Sanders Morris Harris sold 56 Aptose Biosciences, Inc. shares in Q1 2023, an estimated $14.7K.
  • Sanders Morris Harris first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 14 quarters.
  • Sanders Morris Harris's Aptose Biosciences, Inc. position peaked at $4.23M in Q4 2020.
  • 44 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2023.

Based on Sanders Morris Harris's 13F filing for Q1 2023, filed 7 Apr 2023.